Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection

2007165 citationsJournal Articlegold Open Access

Authors

Further studies are warranted to determine the clinical utility of anti-RAGE antibody as a novel treatment for sepsis.

Good health and well-being

Published in: Critical Care

Volume 11, Issue 6, pp. R122-R122

Field-Weighted Citation Impact: 8.38